UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
July, 2025
Commission File Number 001-10306
NatWest Group plc
250 Bishopsgate,
London, EC2M 4AA
United Kingdom
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
The
following information was issued as Company announcements in
London, England and is furnished pursuant to General Instruction B
to the General Instructions to Form 6-K:
|
Exhibit No. 1
|
Commencement of Share Buyback Programme dated 28 July
2025
|
Exhibit No. 1
NatWest Group plc
28 July 2025
Commencement of Share Buyback Programme
NatWest Group plc (the "Company") announces the commencement of its
programme to buy back ordinary shares in the Company with a nominal
value of £1.0769* each
("Ordinary Shares").
On 25 July 2025, the Company announced its half year results and a
share buyback programme (the "2025 Programme") of up to £750
million. The 2025 Programme will commence on 28 July 2025 and
will end no later than 13 February 2026, provided that the term of
the 2025 Programme may be extended to end no later than 13 March
2026 to account for any days where usual trading has not been
possible because of market events during the term of the 2025
Programme.
The 2025 Programme, the purpose of which is to reduce the Company's
issued share capital, will take place within the limitations of the
authority granted by shareholders to the Board of the Company at
its Annual General Meeting, held on 23 April 2025 (the "2025
Authority").
The maximum number of Ordinary Shares that can be purchased by the
Company under the 2025 Programme is 807,750,182**.
The Company has entered into non-discretionary instructions with
Merrill Lynch International to conduct the Programme on its behalf
and to make trading decisions under the Programme independently of
the Company.
The Company intends to cancel the repurchased Ordinary
Shares.
* The
nominal value of Ordinary Shares without rounding is
£1.076923076923077 per share.
** 10% of the issued ordinary share capital as at 13 March 2025, as
approved at the Annual
General Meeting, held
on 23 April 2025.
Further information:
Investor Relations
+ 44 (0)207 672 1758
Media Relations
+44 (0)131 523 4205
Legal Entity Identifier: 2138005O9XJIJN4JPN90
Disclaimer
This announcement is for information purposes only and does not
constitute or form a part of an offer to sell or a solicitation of
an offer to purchase, or the solicitation to sell, any securities
of the Company.
Forward-looking statements
This announcement may include forward-looking statements within the
meaning of the United States Private Securities Litigation Reform
Act of 1995, such as statements with respect to NatWest Group's
financial condition, results of operations and business, including
its strategic priorities, financial, investment and capital
targets, and climate and sustainability related targets,
commitments and ambitions described herein. Statements that are not
historical facts, including statements about NatWest Group's
beliefs and expectations, are forward-looking statements. Words,
such as 'expect', 'estimate', 'project', 'anticipate', 'commit',
'believe', 'should', 'intend', 'will', 'plan', 'could', 'target',
'goal', 'objective', 'may', 'outlook', 'prospects' and similar
expressions or variations on these expressions are intended to
identify forward-looking statements. In particular, this
announcement may include forward-looking statements relating , but
not limited to: its 2025 Programme and the details thereto; NatWest
Group's outlook, guidance and targets (including in relation to
RoTE, total income, other operating expenses, loan impairment rate,
CET1 ratio, RWA levels, payment of dividends and participation in
directed buybacks), its financial position, profitability and
financial performance, the implementation of its strategy, its
access to adequate sources of liquidity and funding, its regulatory
capital position and related requirements, its impairment losses
and credit exposures under certain specified scenarios, substantial
regulation and oversight, ongoing legal, regulatory and
governmental actions and investigations. Forward-looking
statements are subject to a number of risks and uncertainties that
might cause actual results and performance to differ materially
from any expected future results or performance expressed or
implied by the forward-looking statements. Factors that could cause
or contribute to differences in current expectations include, but
are not limited to, future growth initiatives (including
acquisitions, joint ventures and strategic partnerships), the
outcome of legal, regulatory and governmental actions and
investigations, the level and extent of future impairments and
write-downs, legislative, political, fiscal and regulatory
developments, accounting standards, competitive conditions,
technological developments, interest and exchange rate
fluctuations, general economic and political conditions and
uncertainties, exposure to third party risk, operational risk,
conduct risk, cyber, data and IT risk, financial crime risk, key
person risk and credit rating risk and the impact of climate and
sustainability related risks and the transitioning to a net zero
economy. These and other factors, risks and uncertainties that may
impact any forward-looking statement or NatWest Group plc's actual
results are discussed in NatWest Group plc's 2024 Annual Report and
Accounts on Form 20-F, NatWest
Group's Interim
Management Statement for
Q1 and H1 2025 on Form 6-K, and
its other public filings. The forward-looking statements contained
in this announcement speak only as of the date of this announcement
and NatWest Group plc does not assume or undertake any obligation
or responsibility to update any of the forward-looking statements
contained in this announcement, whether as a result of new
information, future events or otherwise, except to the extent
legally required.
No Purchases in the United States and No Purchases of American
Depositary Receipts ("ADRs")
Purchases of Ordinary Shares under the Programme will be made
outside the United States only. There will be no purchases of
Ordinary Shares from within the United States or from persons known
to be located in the United States, and there will be no purchases
of the Company's ADRs under the Programme.
SIGNATURE
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
|
|
|
NatWest Group plc
(Registrant)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date:
|
31 July
2025
|
|
|
By:
|
/s/
Mark Stevens
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name:
|
Mark
Stevens
|
|
|
|
|
|
|
Title:
|
Assistant
Secretary
|
|
